CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies
3.4. Reimbursement scenario
3.4.1. Developed regions
3.4.2. Developing regions
3.5. Government regulations
3.6. Top player positioning, 2017
3.7. Porters five forces analysis
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Affordable good quality care
3.8.1.2. Availability of quality care
3.8.1.3. Accessible information and care
3.8.1.4. Assistance and support from government agencies and associations
3.8.2. Restraints
3.8.2.1. Limited coverage and lengthy partial reimbursement by payers
3.8.2.2. Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues
3.8.3. Opportunities
3.8.3.1. Overseas promotional offices is a key source of medical tourists
3.8.3.2. Wider hospital network under insurance coverage for cashless transactions
3.8.4. Impact analyses
CHAPTER 4: MEDICAL TOURISM MARKET, BY TREATMENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Dental Treatment
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.3. Cosmetic Treatment
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.4. Cardiovascular treatment
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.5. Orthopedic treatment
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.6. Neurological treatment
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.7. Cancer treatment
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.8. Fertility treatment
4.8.1. Key market trends, growth factors, and opportunities
4.8.2 Market size and forecast, by region
4.9. Other treatments
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
CHAPTER 5: MEDICAL TOURISM MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by country
5.2.3. Market size and forecast, by treatment type
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. Europe
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by country
5.3.3. Market size and forecast, by treatment type
5.3.3.1. UK market size and forecast
5.3.3.2. Germany market size and forecast
5.3.3.3. France market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. Asia-Pacific
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by country
5.4.3. Market size and forecast, by treatment type
5.4.3.1. India market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Indonesia market size and forecast
5.4.3.4. Singapore market size and forecast
5.4.3.5. Malaysia market size and forecast
5.4.3.6. Thailand market size and forecast
5.4.3.7. South Korea market size and forecast
5.4.3.8. Taiwan market size and forecast
5.4.3.9. Rest of Europe market size and forecast
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by country
5.5.3. Market size and forecast, by treatment type
5.5.3.1. Brazil market size and forecast
5.5.3.2. Venezuela market size and forecast
5.5.3.3. Costa Rica market size and forecast
5.5.3.4. UAE market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of Europe market size and forecast
CHAPTER 6: COMPANY PROFILES
6.1. Apollo Hospitals Enterprise Limited
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. FORTIS HEALTHCARE LIMITED
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. Asian Heart Institute
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.4. Kpj Healthcare Berhad
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments
6.5. NTT Medical Center Tokyo
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.6. SEOUL NATIONAL UNIVERSITY HOSPITAL.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.7. UZ Leuven
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.8. Wooridul Spine Hospital
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Product Portfolio
6.9. Aditya Birla Memorial Hospital
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.10. Barbados Fertility Center
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.11. Prince Court Medical Centre
6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments
6.11.4. Product portfolio
6.12. Samitivej PCL.
6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product portfolio